A Patent Review on the Therapeutic Application of Monoclonal Antibodies in COVID-19

A Patent Review on the Therapeutic Application of Monoclonal Antibodies in COVID-19

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) contains spike proteins that assist the virus in entering host cells. In the absence of a specific intervention, efforts are afoot throughout the world to find an effective treatment for SARS-CoV-2. Through innovative techniques, monoclona...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Syed Mohammed Basheeruddin Asdaq, Syed Imam Rabbani, Meshary Alkahtani, Meshal Meshary Aldohyan, Abdullah Mohammad Alabdulsalam, Majed Sadun Alshammari, Saleh Ahmad Alajlan, Aljawharah Binrokan, Yahya Mohzari, Ahmed Alrashed, Mohammed Kanan Alshammari, Mohd. Imran, Naira Nayeem
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
monoclonal antibodies
innovation
patent reviews
COVID-19
therapeutic application
Biology (General)
QH301-705.5
Chemistry
QD1-999
Acceso en línea:https://doaj.org/article/0fb05dad1ca24fa887ff4317570027ad
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/0fb05dad1ca24fa887ff4317570027ad

Ejemplares similares